GH Research PLC

GHRSStocksPharmaceuticals MajorIrelandNasdaqUSD

Price

$22.02

Today

-4.0%

YTD

+81.6%

About

GH Research PLC is a renowned company specialising in creating high-quality medical treatment of psychiatric and neurological disorders, operating from Ireland. Navigating the health and pharmaceutical sectors, GH Research PLC delivers top-tier research services, rooted in unbiased, rigorous science. GH Research PLC works in the larger ecosystem of medical research and healthcare, focusing on research into therapies for Treatment Resistant Depression (TRD). Diversify your virtual portfolio by following GHRS shares on eToro.

Price chart

Closing price history for GHRS (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-23.24

P/S (TTM)0.00

P/B (TTM)4.38

Market cap$1.57B

Cap tierSmall-cap

Industry avg P/E-7.37

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-18.79%

ROA-18.16%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$0.99

Free cash flow$-52.46M

Total debt$360,000.00

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.93

Employees73

Next earnings5 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.